Advances in Vaccines for Melanoma

被引：2
作者：
Cui, Can [1 ,2 ]
Ott, Patrick A. [2 ,3 ,4 ,5 ]
Wu, Catherine J. [2 ,3 ,4 ,5 ]
机构：
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 05期
关键词：
Melanoma; Neoantigen; Personalized cancer vaccine; Immunotherapy; TUMOR MUTATIONAL BURDEN; CELL-BASED IMMUNOTHERAPY; CYTOLYTIC T-LYMPHOCYTES; CLINICAL-RESPONSE; SOLID TUMORS; CANCER; IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB; BLOCKADE;
D O I：
10.1016/j.hoc.2024.05.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1045 / 1060
页数：16
相关论文
共 50 条
  • [41] Melanoma vaccines
    Riley, Lee B.
    Agarwala, Sanjiv S.
    EXPERT REVIEW OF VACCINES, 2008, 7 (07) : 937 - 949
  • [42] Melanoma vaccines
    Perales, MA
    Wolchok, JD
    CANCER INVESTIGATION, 2002, 20 (7-8) : 1012 - 1026
  • [43] Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy
    Mehta, Apoorva
    Motavaf, Mateen
    Nebo, Ikenna
    Luyten, Sophia
    Osei-Opare, Kofi D.
    Gru, Alejandro A.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [44] The Emerging Role of Surgery for Patients With Advanced Melanoma Treated With Immunotherapy
    Puza, Charles J.
    Bressler, Elizabeth Schell
    Terando, Alicia M.
    Howard, John Harrison
    Brown, Michael C.
    Hanks, Brent
    Salama, April K. S.
    Beasley, Georgia M.
    JOURNAL OF SURGICAL RESEARCH, 2019, 236 : 209 - 215
  • [45] Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
    Dummer, Reinhard
    Hoeller, Christoph
    Gruter, Isabella Pezzani
    Michielin, Olivier
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (06) : 683 - 695
  • [46] Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population
    Wei, Khor Zhong
    Baxter, Mark
    Casasola, Richard
    MELANOMA MANAGEMENT, 2019, 6 (01)
  • [47] Melanoma vaccines and viral-based immunotherapies: a special focus issue from Melanoma Management Foreword
    Dillman, Robert O.
    Dennis-Beron, Sebastian
    MELANOMA MANAGEMENT, 2016, 3 (04) : 245 - 246
  • [48] Overview of melanoma vaccines: Active specific immunotherapy for melanoma patients
    Ollila, DW
    Kelley, MC
    Gammon, G
    Morton, DL
    SEMINARS IN SURGICAL ONCOLOGY, 1998, 14 (04): : 328 - 336
  • [49] New trends in antitumor vaccines in melanoma
    Vasquez, Marcos
    Tenesaca, Shirley
    Berraondo, Pedro
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (19) : 1 - 6
  • [50] Immunotherapy for Melanoma
    Albittar, Aya A.
    Alhalabi, Omar
    Oliva, Isabella C. Glitza
    IMMUNOTHERAPY, 3RD EDITION, 2020, 1244 : 51 - 68
12345